Impact of Tumor Size on Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiotherapy
A MTD up to 10 cm did not significantly impact in-field progression following SABR. Although the prescribed dose of 48 Gy in five to six fractions can achieve superior in-field control, most treatment failures were due to out-field relapse.
Authors
- Shang-Wen Chen (ORCID: https://orcid.org/0000-0001-7480-2864)
- Wen Lyn Ho
- Ying‐Chun Lin (ORCID: https://orcid.org/0000-0001-7554-2427)
- Ji‐An Liang (ORCID: https://orcid.org/0000-0002-4170-7155)
- YAN-CI JHUANG
Institutions
- China Medical University (TW)
- China Medical University Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-08-28
- DOI
- https://doi.org/10.21873/anticanres.17754
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00